Pharmacokinetics of amoxycillin/clavulanic acid in serum and ascitic fluid in cirrhotic patients

J Antimicrob Chemother. 1989 Apr;23(4):605-11. doi: 10.1093/jac/23.4.605.

Abstract

A combination of amoxycillin and clavulanic acid (Augmentin) might be useful for first-line treatment of spontaneous bacterial peritonitis in patients with cirrhosis. We have studied the pharmacokinetics of amoxycillin/clavulanic acid in serum and ascitic fluid of six cirrhotic patients. A total of 66 simultaneous serum and ascitic samples were analysed. Following iv injection of 1 g amoxycillin plus 0.2 g clavulanic acid, the ascites to serum AUC ratio was 1.38 for amoxycillin and 1.01 for clavulanic acid, indicating a good distribution of these drugs into the ascitic fluid. In this study, experimental data were fitted to a three compartment body model which revealed that the prolonged serum half-lives of amoxycillin (274 min) and clavulanic acid (200 min) were probably due to the slow return from the ascitic compartment.

MeSH terms

  • Adult
  • Aged
  • Amoxicillin / blood
  • Amoxicillin / pharmacokinetics*
  • Ascitic Fluid / metabolism*
  • Biological Assay
  • Clavulanic Acids / blood
  • Clavulanic Acids / pharmacokinetics*
  • Female
  • Humans
  • Liver Cirrhosis / metabolism*
  • Male
  • Middle Aged
  • Models, Biological

Substances

  • Clavulanic Acids
  • Amoxicillin